This review synthesised existing evidence on racial disparities in pulse oximeter accuracy, quantified the degree of bias, evaluated clinical effects, highlighted implications for practice, and ...

Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...

Near-infrared spectroscopy (NIRS) is an increasingly accepted noninvasive method for monitoring regional cerebral oxygen saturation (rScO 2) and cerebral fractional tissue oxygen extraction (cFTOE) in ...

12月17日，赛诺菲（Sanofi）宣布，第二代心肌肌球蛋白抑制剂(CMI)阿夫凯泰片正式获得中国国家药品监督管理局(NMPA)批准，用于治疗纽约心脏协会(NYHA)心功能分级II-III级的梗阻性肥厚型心肌病(HCM)成人患者，以改善运动能力和症状。 阿夫凯泰片是肥厚型心肌病领域 ...

Individuals with Fontan circulation are at risk of late mortality from both cardiac and noncardiac causes. Despite the known risk of mortality, referral indications for advanced heart failure care ...

The last 3 decades have seen a revolution in our understanding of the physiology and pathophysiology of iron metabolism in the cardiovascular system. In this review, we highlight the key role of iron ...